CAMLPR Transfusion Practice Test

Neonatal transfusion requires a highly cautious approach to protect the infant’s small, developing circulatory and immune systems. The best practice emphasizes using small-volume transfusions in carefully controlled aliquots, rather than large volumes that can overwhelm a fragile circulation and lead to congestive heart failure or pulmonary edema. Ensuring ABO compatibility helps prevent acute hemolytic reactions that can occur even in newborns due to maternal antibodies circulating after birth.

Minimizing donor exposures reduces the risk of alloimmunization, transfusion reactions, and infectious complications over time, which is particularly important for babies who may need multiple transfusions in the first weeks of life. Leukoreduction—removing white blood cells from blood products—lowers the chances of febrile nonhemolytic reactions, decreases alloimmunization to donor HLA antigens, and reduces CMV transmission risk, all of which are important for neonates with immature immune systems.

Careful monitoring for circulatory overload is essential, since neonates can quickly develop signs of volume overload with transfusion. This includes watching for changes in vitals, respiratory status, and signs of edema, and adjusting the transfusion rate or pausing as needed.

Choosing this combination of practices—small-volume transfusions, ABO compatibility, minimal donor exposures, leukoreduction, and vigilant monitoring—addresses the major risks unique to transfusing newborns. The other approaches either risk overload, skip protective leukoreduction, or neglect monitoring, which are inappropriate for neonatal patients.